Trexquant Investment’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-51,695
Closed -$296K 1657
2022
Q1
$296K Sell
51,695
-2,109
-4% -$12.1K 0.01% 1010
2021
Q4
$491K Buy
53,804
+15,650
+41% +$143K 0.03% 649
2021
Q3
$408K Buy
38,154
+13,925
+57% +$149K 0.03% 617
2021
Q2
$376K Sell
24,229
-4,164
-15% -$64.6K 0.03% 613
2021
Q1
$460K Buy
+28,393
New +$460K 0.04% 547
2020
Q4
Sell
-72,449
Closed -$1.07M 1219
2020
Q3
$1.07M Buy
72,449
+44,364
+158% +$658K 0.07% 394
2020
Q2
$413K Sell
28,085
-51,546
-65% -$758K 0.03% 744
2020
Q1
$935K Buy
79,631
+31,980
+67% +$375K 0.07% 442
2019
Q4
$1.12M Buy
+47,651
New +$1.12M 0.07% 343
2019
Q2
Sell
-70,639
Closed -$1.73M 950
2019
Q1
$1.73M Buy
+70,639
New +$1.73M 0.12% 247
2018
Q4
Sell
-21,408
Closed -$678K 1144
2018
Q3
$678K Sell
21,408
-4,048
-16% -$128K 0.05% 461
2018
Q2
$989K Buy
+25,456
New +$989K 0.07% 378
2018
Q1
Sell
-51,907
Closed -$940K 1207
2017
Q4
$940K Buy
51,907
+39,131
+306% +$709K 0.1% 310
2017
Q3
$206K Buy
+12,776
New +$206K 0.05% 625
2017
Q1
Sell
-26,915
Closed -$353K 1182
2016
Q4
$353K Buy
+26,915
New +$353K 0.06% 580
2016
Q1
Sell
-11,072
Closed -$296K 1023
2015
Q4
$296K Buy
+11,072
New +$296K 0.03% 854